The "acqui-hire" strategy is on fire in this battle among tech titans seeking AI dominance and a Goliath just beat David ...

The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

AI models have just taken a startling step toward autonomy. In a shocking experiment, OpenAI’s o3 model rewrote its own code ...

Software engineer workflows have been transformed in recent years by an influx of AI coding tools. However, a new study calls ...

Bill Gates has warned that AI will replace many jobs, but says coding will stay a fully human profession, even hundreds of ...

Tech giants like Meta and Google have been making huge investments and poaching talent from AI startups like ScaleAI and ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Below are the most-read DIGITIMES Asia stories from July 7 to July 13, 2025. This week's top three highlights include China’s ...

Despite hefty investment into AI, Microsoft is struggling to make headway against ChatGPT and a host of other AI assistants.

Glenmark’s progress with a cancer treatment shows the potential of Indian pharma to move from generics to drug discovery. With tech-enabled therapies evolving fast, new inflection points spell a ...

Tyson Jominy routinely summons Microsoft Corp.’s AI assistant by tapping the Copilot key on his computer. Not because he ...